Pacific Wealth Management reported 9 positions worth $20.47M for the quarter ended Sep 30, 2026, up 0.7% on the prior quarter. It opened 1 new position, added to 1, trimmed 6 and exited 2. Its largest holding is AbbVie Inc. at 48.6% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| HALO Halozyme Therapeutics, Inc. | -3,217 | -59.6% | $355.16K | 1.18% |
| VSAT Viasat Inc | -3,629 | -100.0% | $325.92K | Exited |
| QCOM Qualcomm Inc | -1,133 | -100.0% | $209.33K | Exited |
| MSFT Microsoft Corp | -318 | -24.8% | $163.08K | 2.41% |
| ABT Abbott Laboratories | -974 | -4.1% | $96.26K | 11.11% |
| AAPL Apple Inc. | -237 | -11.0% | $78.93K | 3.13% |
| ABBV AbbVie Inc. | -229 | -0.6% | $59.90K | 48.6% |
| BRK-B Berkshire Hathaway Inc | -40 | -6.1% | $19.92K | 1.49% |
| Holding | Shares | Trade Value | Weight |
|---|---|---|---|
| GLD Spdr Gold Trust | +3,331 | $1.27M | 6.2% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ABBV AbbVie Inc. | Healthcare | 38.0K | $9.95M | 48.6% | -229 | -0.6% | Reduced | 0% |
| 2 | INTC Intel Corp | Technology | 40.8K | $4.91M | 23.96% | +278 | +0.7% | Added | 0% |
| 3 | ABT Abbott Laboratories | Healthcare | 23.0K | $2.27M | 11.11% | -974 | -4.1% | Reduced | 0% |
| 4 | GLD Spdr Gold Trust | Others | 3,331 | $1.27M | 6.2% | +3,331 | – | New | 0% |
| 5 | AAPL Apple Inc. | Technology | 1,922 | $640.06K | 3.13% | -237 | -11.0% | Reduced | 0% |
| 6 | MSFT Microsoft Corp | Technology | 963 | $493.86K | 2.41% | -318 | -24.8% | Reduced | 0% |
| 7 | ONTO Onto Innovation Inc. | Technology | 1,287 | $396.16K | 1.93% | 0 | 0.0% | Unchanged | 0% |
| 8 | BRK-B Berkshire Hathaway Inc | Financial Services | 612 | $304.75K | 1.49% | -40 | -6.1% | Reduced | 0% |
| 9 | HALO Halozyme Therapeutics, Inc. | Healthcare | 2,184 | $241.11K | 1.18% | -3,217 | -59.6% | Reduced | 0% |
Tip. Select a row to see that position’s full history at Pacific Wealth Management.
As of its Q3 2026 13F filing, Pacific Wealth Management’s five largest positions were AbbVie Inc. (ABBV) at 48.6%, Intel Corp (INTC) at 24.0%, Abbott Laboratories (ABT) at 11.1%, Spdr Gold Trust (GLD) at 6.2%, Apple Inc. (AAPL) at 3.1% of the reported portfolio.
Pacific Wealth Management reported a 13F portfolio worth $20.47M across 9 positions for Q3 2026. That is up 0.7% from the previous quarter.
Its largest purchases by value were Spdr Gold Trust ($1.27M), Intel Corp ($33.42K). It opened 1 new positions.
Its largest sales by value were Halozyme Therapeutics, Inc. ($355.16K), Viasat Inc ($325.92K), Qualcomm Inc ($209.33K). It exited 2 positions entirely.
From the Form 13F-HR reports Pacific Wealth Management files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.